Literature DB >> 12547699

Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells.

Hongming Qiu1, F William Orr, Derrek Jensen, Hui Helen Wang, Alan R McIntosh, Brian B Hasinoff, Dwight M Nance, Susan Pylypas, Ke Qi, Chun Song, Ruth J Muschel, Abu-Bakr Al-Mehdi.   

Abstract

Metastatic cancer cells seed the lung via blood vessels. Because endothelial cells generate nitric oxide (NO) in response to shear stress, we postulated that the arrest of cancer cells in the pulmonary microcirculation causes the release of NO in the lung. After intravenous injection of B16F1 melanoma cells, pulmonary NO increased sevenfold throughout 20 minutes and approached basal levels by 4 hours. NO induction was blocked by N(G)-nitro-L-arginine methyl ester (L-NAME) and was not observed in endothelial nitric oxide synthase (eNOS)-deficient mice. NO production, visualized ex vivo with the fluorescent NO probe diaminofluorescein diacetate, increased rapidly at the site of tumor cell arrest, and continued to increase throughout 20 minutes. Arrested tumor cells underwent apoptosis with apoptotic counts more than threefold over baseline at 8 and 48 hours. Neither the NO signals nor increased apoptosis were seen in eNOS knockout mice or mice pretreated with L-NAME. At 48 hours, 83% of the arrested cells had cleared from the lungs of wild-type mice but only approximately 55% of the cells cleared from eNOS-deficient or L-NAME pretreated mice. eNOS knockout and L-NAME-treated mice had twofold to fivefold more metastases than wild-type mice, measured by the number of surface nodules or by histomorphometry. We conclude that tumor cell arrest in the pulmonary microcirculation induces eNOS-dependent NO release by the endothelium adjacent to the arrested tumor cells and that NO is one factor that causes tumor cell apoptosis, clearance from the lung, and inhibition of metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547699      PMCID: PMC1851169          DOI: 10.1016/S0002-9440(10)63835-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Apoptosis: an early event in metastatic inefficiency.

Authors:  C W Wong; A Lee; L Shientag; J Yu; Y Dong; G Kao; A B Al-Mehdi; E J Bernhard; R J Muschel
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

Review 2.  Nitric oxide-induced apoptosis in tumor cells.

Authors:  V Umansky; V Schirrmacher
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

Review 3.  Natural killer cells and nitric oxide.

Authors:  M G Cifone; S Ulisse; A Santoni
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

4.  Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro.

Authors:  J Carretero; E Obrador; J M Esteve; A Ortega; J A Pellicer; F V Sempere; J M Estrela
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

5.  Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.

Authors:  M Vakkala; K Kahlos; E Lakari; P Pääkkö; V Kinnula; Y Soini
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

6.  B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.

Authors:  H H Wang; A R McIntosh; B B Hasinoff; E S Rector; N Ahmed; D M Nance; F W Orr
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

7.  Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.

Authors:  B Wang; Q Xiong; Q Shi; X Le; J L Abbruzzese; K Xie
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

8.  Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion.

Authors:  B Wang; Q Xiong; Q Shi; D Tan; X Le; K Xie
Journal:  Int J Cancer       Date:  2001-03-01       Impact factor: 7.396

9.  Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice.

Authors:  G Cao; J Su; W Lu; F Zhang; G Zhao; D Marteralli; Z Dong
Journal:  Cancer Gene Ther       Date:  2001-07       Impact factor: 5.987

Review 10.  Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis.

Authors:  F W Orr; H H Wang
Journal:  Surg Oncol Clin N Am       Date:  2001-04       Impact factor: 3.495

View more
  23 in total

1.  Tissue protection and endothelial cell signaling by 20-HETE analogs in intact ex vivo lung slices.

Authors:  Elizabeth R Jacobs; Sreedhar Bodiga; Irshad Ali; Aaron M Falck; John R Falck; Meetha Medhora; Anuradha Dhanasekaran
Journal:  Exp Cell Res       Date:  2012-06-09       Impact factor: 3.905

2.  Inhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows.

Authors:  Lin Zhang; Min Zeng; Bingmei M Fu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-08       Impact factor: 4.733

Review 3.  Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.

Authors:  Ryan D Roberts; Michael M Lizardo; Damon R Reed; Pooja Hingorani; Jason Glover; Wendy Allen-Rhoades; Timothy Fan; Chand Khanna; E Alejandro Sweet-Cordero; Thomas Cash; Michael W Bishop; Meenakshi Hegde; Aparna R Sertil; Christian Koelsche; Lisa Mirabello; David Malkin; Poul H Sorensen; Paul S Meltzer; Katherine A Janeway; Richard Gorlick; Brian D Crompton
Journal:  Cancer       Date:  2019-07-29       Impact factor: 6.860

Review 4.  Stepping out of the flow: capillary extravasation in cancer metastasis.

Authors:  Fayth L Miles; Freddie L Pruitt; Kenneth L van Golen; Carlton R Cooper
Journal:  Clin Exp Metastasis       Date:  2007-09-29       Impact factor: 5.150

5.  Sinusoidal tumor angiogenesis is a key component in hepatocellular carcinoma metastasis.

Authors:  Takashi Sugino; Tomiko Yamaguchi; Nobuo Hoshi; Takashi Kusakabe; Go Ogura; Steve Goodison; Toshimitsu Suzuki
Journal:  Clin Exp Metastasis       Date:  2008-08-20       Impact factor: 5.150

6.  Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver.

Authors:  Ningling Kang Decker; Soha S Abdelmoneim; Usman Yaqoob; Helen Hendrickson; Joe Hormes; Mike Bentley; Henry Pitot; Raul Urrutia; Greg J Gores; Vijay H Shah
Journal:  Am J Pathol       Date:  2008-08-28       Impact factor: 4.307

7.  Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis.

Authors:  Qin Chen; Tsunaki Hongu; Takanobu Sato; Yi Zhang; Wahida Ali; Julie-Ann Cavallo; Adrianus van der Velden; Huasong Tian; Gilbert Di Paolo; Bernhard Nieswandt; Yasunori Kanaho; Michael A Frohman
Journal:  Sci Signal       Date:  2012-11-06       Impact factor: 8.192

8.  Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy.

Authors:  Shiro Fujita; Katsuhiro Masago; Yukimasa Hatachi; Akiko Fukuhara; Akito Hata; Reiko Kaji; Young Hak Kim; Tadashi Mio; Michiaki Mishima; Nobuyuki Katakami
Journal:  BMC Med Genet       Date:  2010-11-30       Impact factor: 2.103

9.  CXCR4/CXCL12 participate in extravasation of metastasizing breast cancer cells within the liver in a rat model.

Authors:  Claudia Wendel; André Hemping-Bovenkerk; Julia Krasnyanska; Sören Torge Mees; Marina Kochetkova; Sandra Stoeppeler; Jörg Haier
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

10.  Modulators of arginine metabolism support cancer immunosurveillance.

Authors:  Giusy Capuano; Nicolò Rigamonti; Matteo Grioni; Massimo Freschi; Matteo Bellone
Journal:  BMC Immunol       Date:  2009-01-09       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.